A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy Volunteers

NCT05742126 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HSK36273
DRUG: Placebo
DRUG: Heparin sodium injection

Sponsor

Haisco Pharmaceutical Group Co., Ltd.